COURSE DESCRIPTION:
A multidisciplinary team approach to care is fostered through peer-to-peer discussion and collaboration. The team discussion pertaining to diagnosis and treatment includes radiological and pathological findings and immunohistochemical testing to bridge gaps across the continuum of care and enhance the overall quality of patient-centered oncology care.

TARGET AUDIENCE:
Neurosurgeons, Neurologists, Interventional Neuroradiologists, Radiation Oncologists, Medical Oncologists, Pathologists, Radiologists, Intensivists, Internal Medicine Physicians, Allied Health Practitioners, Nurses, Pharmacists, Occupational Therapists and all personnel involved in the care of the brain and spine.

LEARNING OBJECTIVES:

•    Improve clinical decision making, clinical outcomes, and patient experience via a multidisciplinary team approach. Group discussion include prospective patient care management, national treatment guidelines, staging, and options and eligibility for genetic testing, clinical research studies, and supportive care services.

•    Develop a comprehensive treatment plan for brain and spine oncology patients leveraging imaging and pathology testing results and meet Commission on Cancer accreditation standards compliance. 

FACULTY AND DISCLOSURES:
Moderator:
Yazmin Odia, M.D., M.S., FAAN
Chief, Neuro-Oncology
Miami Cancer Institute
Member, Memorial Sloan Kettering Cancer Alliance
Miami, Florida

Ady L. Lazcano, APRN
Miami Cancer Institute

Elizabeth Zike, APRN
Miami Cancer Institute
 

Yazmin Odia, M.D., M.S., FAAN,  has received research support from Novocure – trial support BMS, is a consultant with Istari Oncology, Inc., and on the scientific safety monitoring board with Gammatile GT. 

Ady L. Lazcano and Elizabeth Zike, interprofessional coordinators for this educational activity, have no relevant financial relationships with ineligible companies* to disclose. 

DMT coordinators and others involved in the planning, development, and editing/review of the content have no relevant financial relationships to disclose with ineligible companies*

*Ineligible companies - Companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients
 

Disclosure Policy and Disclaimer

ACCREDITATION STATEMENTS AND CREDITS

Baptist Health South Florida is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Baptist Health South Florida designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.   

This activity has been approved for 1 credit hour, CE Broker Course #20-448262, by the Florida Boards of Medicine and Osteopathic Medicine.  

This activity has also been approved for 1 credit for Nursing, Pharmacy and Occupational Therapy. Baptist Health South Florida CE Broker Provider #50-182.

American Board of Surgery - Maintenance of Certification (MOC) - Accredited CME - Complex General Surgical Oncology

Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn credit toward the CME of the American Board of Surgery’s Continuous Certification program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABS credit.

Successful completion of this course is submitted to specialty boards through the ACCME's PARS system.